NYSE: GLGlobe Life Inc Stock
$86.88-2.61 (-2.92%)
Updated May 9, 2024
GL Price
$86.88
Fair Value Price
N/A
Market Cap
$8.02B
52 Week Low
$38.95
52 Week High
$132.00
P/E
8.19x
P/B
1.59x
P/S
1.97x
PEG
2.35x
Dividend Yield
1.05%
Revenue
$5.54B
Earnings
$1.00B
Gross Margin
47.9%
Operating Margin
24.2%
Profit Margin
18.1%
Debt to Equity
4.67
Operating Cash Flow
$1B
Beta
1
Next Earnings
N/A
Ex-Dividend
Jul 5, 2024
Next Dividend
Aug 1, 2024
GL Overview
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; and medicare supplement and supplemental health insurance, such as critical illness and accident plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GL ($86.88) is trading above its intrinsic value of $71.19, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GL is good value based on its earnings relative to its share price (8.19x), compared to the US market average (29.92x)
P/E vs Market Valuation
GL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more GL due diligence checks available for Premium users.
Be the first to know about important GL news, forecast changes, insider trades & much more!
GL News
Valuation
GL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.19x
Industry
13.9x
Market
29.92x
GL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
GL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.59x
Industry
1.43x
GL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
GL price to earnings growth (PEG)
For valuing profitable companies with growth potential
GL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
GL's financial health
Profit margin
Revenue
$1.4B
Net Income
$254.2M
Profit Margin
18%
GL's Earnings (EBIT) of $1.34B... subscribe to Premium to read more.
Interest Coverage Financials
GL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$28.6B
Liabilities
$23.5B
Debt to equity
4.67
GL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
GL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$350.8M
Investing
-$731.9M
Financing
$357.0M
GL's operating cash flow ($1.36B)... subscribe to Premium to read more.
Debt Coverage Financials
GL vs Property & Casualty Insurance Stocks
Globe Life Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.